The experts on equipment manufacturers of medical devices and in vitro diagnostic products. MD+DI helps industry professionals develop, design, and manufacture medical products that comply with complex and demanding regulations and market requirements.
Parexel opens Singapore clinical trial supply centre OutSourcing-Pharma.com The company's Clinical Logistical Services also offer risk evaluation and mitigation planning for investigational site supply, technology to track shipments and inventory,...
When Noah Minskoff's mother died of lung cancer in 2007, e-cigarettes were just entering the U.S. market. Minskoff, who had just started medical school in Utah, wondered whether the devices might have saved his mother's life by helping her quit smoking. Later, he sent some samples to his boyhood friend Nathan Terry, a mechanical engineer, and asked for his opinion. Terry, who was working in Germany for the French industrial firm Areva, took apart the products to see how they were made.
After 4 years of prohibition, Laura Chinchilla, President of the Republic of Costa Rica, signed new legislation on April 22, 2014, which allows the private, academic and public sector to once again produce new drugs and medical devices--a breakthrough for the scientific community in the country.
Boehringer Ingelheim has announced that it intends to make drug data from clinical trials stemming back to 1998 accessible as part of efforts to improve research transparency within the industry.
The move is part of a collaboration with fellow pharma companies Sanofi, GlaxoSmithKline, Novartis, Roche and ViiV Healthcare on an online platform to handle requests from researchers for trial data.
Boehringer's chairman Dr Andreas Barner made the announcement at Boehringer's annual company meeting yesterday, following up from a commitment to transparency announced at the same meeting in 2013.
Dr Barner, who also heads R&D at Boehringer, explained that the online platform - available at clinicalstudydatarequest.com - currently contained 50 trials available for which to request patient-level data, but the plan is to reach 500 from all involved parties.
“That's quite a job to achieve. but we have to do it in interest of what data and information can be shared with others,” said Dr Barner.
“We have always argued in favour of transparency and now want a more scientific discussion on the level of trial data and have therefore joined up with several research-based pharmaceutical companies in order to make clinical trials data and documents available to a wider public.” ....
The 87,000-square-foot facility will serve as a distribution hub for the company’s pharmaceutical supply chain management business (Columbus Becomes Center of Pharmaceutical Innovation http://t.co/MnDX1VoNje)...
FDA and Manufacturers Seek a More Secure Drug Supply Chain Pharmaceutical Technology Magazine The DQSA program, together with the upstream supply-chain measures in the FDA Safety and Innovation Act of 2012 (FDASIA), provide FDA and...
Economic Times Air France-KLM to add capacity in cargo business in India Economic Times "Air France, KLM and Martinair Cargo are doing this primarily in response to the needs of the pharmaceutical and healthcare industry.
Sharing your scoops to your social media accounts is a must to distribute your curated content. Not only will it drive traffic and leads through your content, but it will help show your expertise with your followers.
How to integrate my topics' content to my website?
Integrating your curated content to your website or blog will allow you to increase your website visitors’ engagement, boost SEO and acquire new visitors. By redirecting your social media traffic to your website, Scoop.it will also help you generate more qualified traffic and leads from your curation work.
Distributing your curated content through a newsletter is a great way to nurture and engage your email subscribers will developing your traffic and visibility.
Creating engaging newsletters with your curated content is really easy.